ViroScanner AI - Cofounder Project

Headline: AI-Driven Drug Discovery Engine: Turning 6,300+ Molecules into Clinical Leads. Overview: ViroScanner AI is a high-performance molecular screening platform designed to bypass years of traditional R&D. While the frontend is hosted on a sleek, high-conversion Lovable web interface for maximum accessibility, the "brain" of the project is a highly complex Python-based molecular engine. This backend utilizes advanced chemical libraries (RDKit) and state-of-the-art AI (Gemini API) to perform deep structural analysis, valence validation, and multi-objective optimization. Current Milestones: Massive Screening: Already processed over 6,300+ candidates targeting the SARS-CoV-2 Mpro protease. The Diamond Discovery: Successfully identified a specific lead (1-amino-2-naphthol) with a peak Affinity Score (PTS) of 410 and an exceptional Synthetic Accessibility (SA) of 2.59. Validated Logic: The system doesn't just find "strong" molecules; it finds manufacturable ones, boasting a Discovery Efficiency Index of 158.3. The Tech Stack: Core Engine: Complex Python architecture for molecular physics and chemical reasoning. Database: Supabase for real-time, scalable molecular data storage. Frontend: Modern, responsive startup interface built via Lovable, designed for professional investor presentations. What I am looking for: I am the Lead Architect and Founder, focusing 100% on the technical evolution of the scanning engine. I am seeking a Strategic Partner / Co-Founder to take full ownership of Marketing, Business Development, and Commercialization. The Deal: I am looking for an partner who can bring upfront capital (X amount) to scale operations and lead the global promotion of the platform. In exchange, I am offering a significant Revenue Interest Model (X% of all future profits/royalties). If you are a master of marketing and business growth who wants to own the commercial side of a validated BioTech breakthrough—let’s talk